228 related articles for article (PubMed ID: 12876389)
1. Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort.
Pollack IF; Finkelstein SD; Burnham J; Hamilton RL; Yates AJ; Holmes EJ; Boyett JM; Finlay JL
Pediatr Neurosurg; 2003 Sep; 39(3):114-21. PubMed ID: 12876389
[TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
3. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
[TBL] [Abstract][Full Text] [Related]
4. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
[TBL] [Abstract][Full Text] [Related]
5. Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.
Stockhammer F; Thomale UW; Plotkin M; Hartmann C; Von Deimling A
J Neurosurg; 2007 Apr; 106(4):633-7. PubMed ID: 17432715
[TBL] [Abstract][Full Text] [Related]
6. Loss of genetic material within 1p and 19q chromosomal arms in low grade gliomas of central nervous system.
Ręcławowicz D; Stempniewicz M; Biernat W; Limon J; Słoniewski P
Folia Neuropathol; 2013; 51(1):26-32. PubMed ID: 23553134
[TBL] [Abstract][Full Text] [Related]
7. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.
Smith JS; Perry A; Borell TJ; Lee HK; O'Fallon J; Hosek SM; Kimmel D; Yates A; Burger PC; Scheithauer BW; Jenkins RB
J Clin Oncol; 2000 Feb; 18(3):636-45. PubMed ID: 10653879
[TBL] [Abstract][Full Text] [Related]
8. Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies.
Bouvier C; Roll P; Quilichini B; Metellus P; Calisti A; Gilles S; Chinot O; Fina F; Martin PM; Figarella-Branger D
J Neurooncol; 2004 Jun; 68(2):141-9. PubMed ID: 15218950
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.
Kaloshi G; Benouaich-Amiel A; Diakite F; Taillibert S; Lejeune J; Laigle-Donadey F; Renard MA; Iraqi W; Idbaih A; Paris S; Capelle L; Duffau H; Cornu P; Simon JM; Mokhtari K; Polivka M; Omuro A; Carpentier A; Sanson M; Delattre JY; Hoang-Xuan K
Neurology; 2007 May; 68(21):1831-6. PubMed ID: 17515545
[TBL] [Abstract][Full Text] [Related]
10. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
Marko NF; Prayson RA; Barnett GH; Weil RJ
Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.
McDonald JM; See SJ; Tremont IW; Colman H; Gilbert MR; Groves M; Burger PC; Louis DN; Giannini C; Fuller G; Passe S; Blair H; Jenkins RB; Yang H; Ledoux A; Aaron J; Tipnis U; Zhang W; Hess K; Aldape K
Cancer; 2005 Oct; 104(7):1468-77. PubMed ID: 16088966
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas.
Godfraind C; Rousseau E; Ruchoux MM; Scaravilli F; Vikkula M
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):462-71. PubMed ID: 14507338
[TBL] [Abstract][Full Text] [Related]
13. Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q.
Grzendowski M; Wolter M; Riemenschneider MJ; Knobbe CB; Schlegel U; Meyer HE; Reifenberger G; Stühler K
Neuro Oncol; 2010 Mar; 12(3):243-56. PubMed ID: 20167812
[TBL] [Abstract][Full Text] [Related]
14. Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.
Ino Y; Zlatescu MC; Sasaki H; Macdonald DR; Stemmer-Rachamimov AO; Jhung S; Ramsay DA; von Deimling A; Louis DN; Cairncross JG
J Neurosurg; 2000 Jun; 92(6):983-90. PubMed ID: 10839259
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
Huang L; Jiang T; Yuan F; Li GL; Xu LX; Cui Y
Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):752-8. PubMed ID: 22335907
[TBL] [Abstract][Full Text] [Related]
16. Detecting chromosomal alterations at 1p and 19q by FISH and DNA fragment analysis--a comparative study in human gliomas.
Broholm H; Born PW; Guterbaum D; Dyrbye H; Laursen H
Clin Neuropathol; 2008; 27(6):378-87. PubMed ID: 19130734
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
Reifenberger J; Reifenberger G; Liu L; James CD; Wechsler W; Collins VP
Am J Pathol; 1994 Nov; 145(5):1175-90. PubMed ID: 7977648
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis.
Zhao J; Ma W; Zhao H
Neuro Oncol; 2014 Jan; 16(1):103-12. PubMed ID: 24311641
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.
Iwamoto FM; Nicolardi L; Demopoulos A; Barbashina V; Salazar P; Rosenblum M; Hormigo A
J Neurooncol; 2008 Jul; 88(3):293-8. PubMed ID: 18345516
[TBL] [Abstract][Full Text] [Related]
20. Calcification on CT is a simple and valuable preoperative indicator of 1p/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas.
Saito T; Muragaki Y; Maruyama T; Komori T; Tamura M; Nitta M; Tsuzuki S; Kawamata T
Brain Tumor Pathol; 2016 Jul; 33(3):175-82. PubMed ID: 26849373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]